Skip to main content
Fig. 3 | BMC Psychiatry

Fig. 3

From: Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments

Fig. 3

Subgroup analysis of changes in body weight and metabolic parameters among different groups after 6 weeks of olanzapine treatment. a Changes in body weight and metabolic parameters among different groups with 1 to 2 years of previous antipsychotics exposure. b Changes in body weight and metabolic parameters among different groups with 2 to 5 years of previous antipsychotics exposure. c Changes in body weight and metabolic parameters among different groups with more than 5 years of previous antipsychotics exposure. A, B, and C represent the antipsychotic-naïve group, low-metabolic-risk antipsychotics group, and high-metabolic-risk antipsychotics group, respectively

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us